1. Home
  2. ATYR vs LPA Comparison

ATYR vs LPA Comparison

Compare ATYR & LPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo aTyr Pharma Inc. Common Stock

ATYR

aTyr Pharma Inc. Common Stock

HOLD

Current Price

$0.83

Market Cap

72.6M

Sector

Health Care

ML Signal

HOLD

LPA

Logistic Properties of the Americas

HOLD

Current Price

$3.18

Market Cap

155.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATYR
LPA
Founded
2005
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
72.6M
155.7M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
ATYR
LPA
Price
$0.83
$3.18
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$8.75
N/A
AVG Volume (30 Days)
3.3M
32.6K
Earning Date
11-06-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.21
Revenue
$190,000.00
$47,536,343.00
Revenue This Year
N/A
N/A
Revenue Next Year
$18,728.88
N/A
P/E Ratio
N/A
$14.19
Revenue Growth
N/A
7.28
52 Week Low
$0.64
$2.55
52 Week High
$7.29
$11.47

Technical Indicators

Market Signals
Indicator
ATYR
LPA
Relative Strength Index (RSI) 47.97 38.89
Support Level $0.70 $3.05
Resistance Level $0.86 $3.60
Average True Range (ATR) 0.06 0.20
MACD 0.04 0.02
Stochastic Oscillator 83.74 1.69

Price Performance

Historical Comparison
ATYR
LPA

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About LPA Logistic Properties of the Americas

Logistic Properties of the Americas is a fully-integrated, internally managed real estate company that develops, owns, and manages a diversified portfolio of warehouse logistics assets in Central America and South America. It focuses on modern Class A logistics real estate in high-growth and high-barrier-to-entry markets that are undersupplied and have low penetration rates. The company has three operating segments, based on geographic regions, consisting of Colombia, Peru, and Costa Rica. The company generates the majority of its revenue from the Costa Rica geographical segment.

Share on Social Networks: